Table 14.1.3
Suggested algorithm for the management of status epilepticus in supportive care patient when cardiorespiratory problems and drug–drug interaction are a concern
MinutesTreatment

0

Stabilize the patient: ABC, protect Airway—ensure Breathing—maintain the Circulation.

> 5

Additional drug therapy may be not required if seizure stops and the cause of status epilepticus is treated

Lorazepam IV, 0.1–0.15 mg/kg in children and 4–8 mg in adult (depending on body weight), at a rate of 2 mg/min; may repeat once after 20 minutes,

or

midazolam IV 0.2 mg/kg as bolus, continuous venous infusion of 0.1–0.6 mg/kg/h. Midazolam is well absorbed also IM and SC, and can be given at the same doses when venous access in not feasible;

midazolam as oral or atomized nasal preparations is also an alternative, at dose of 0.5 mg/kg, 2.5 mg for children, 6–12 months old; 5 mg 1–4 years; 7.5 mg 5–9 years; 10 mg for children 10 years or older,

or

IV diazepam 0.15–0.25 mg/kg, at rate of 5 mg/min, until a total of 20 mg in adults; may repeat once after 5min; rectal diazepam, 0.5 mg/kg or 2.5 mg for children 6–12 months old; 5 mg for 1–4 years; 7.5 mg 5–9 years; 10 mg for children 10 years, or more.

then

IV valproic acid 20–30 mg/kg infused over 15 minutes. However, higher doses, up to 25–60 mg/kg, at 3 mg/kg/min, have been used without serious side effects. This bolus must be followed by continuous infusion of 1–2 mg/kg/h*,

or

IV levetiracetam: 20–30 mg/kg in 100 mL of NaCl 0.9% or 5% glucose infused in 30 minutes: then, after 12 hours, the same in two divided doses.

If status epilepticus does not respond, consider

IV phenytoin 15 (in the elderly)–20 mg/kg, at infusion rate of no more than 50 mg/min in adults or 1 mg/kg/min in children (monitor for hypotension and electrocardigraphic QT prolongation), in normal saline, followed by a dose of 4–8 mg/kg/daily oral or IV.

If ineffective, give supplemental IV phenytoin 5 mg/kg, which can be repeated up to a total dose of 30 mg/kg.

* In some guidelines, phenytoin is suggested before valproic acid, but a number of papers have documented the successful use of IV valproate in status epilepticus, without serious cardiovascular side effects; fosphenytoin is better tolerated than phenytoin, but is not available in all countries.

and

phenobarbital IV, 20 mg/kg, infusion rate of 60 mg/min; caution with respiratory depression, mostly in patients treated before with benzodiazepines; if ineffective, supplemental IV phenobarbital 5–10 mg/kg

> 60: refractory status epilepticus

First consider:  Lacosamide: children 2–2.5 mg/kg infused in 15 minutes then the same dose bid; adults: 200–400 mg in 15 minutes, then 200 mg twice a day

Otherwise refractory status epilepticus to be treated in intensive care unit, where the patient can be treated with general anaesthesia, propofol, pentobarbital, or others drugs (Fernandez and Claassen, 2012)

MinutesTreatment

0

Stabilize the patient: ABC, protect Airway—ensure Breathing—maintain the Circulation.

> 5

Additional drug therapy may be not required if seizure stops and the cause of status epilepticus is treated

Lorazepam IV, 0.1–0.15 mg/kg in children and 4–8 mg in adult (depending on body weight), at a rate of 2 mg/min; may repeat once after 20 minutes,

or

midazolam IV 0.2 mg/kg as bolus, continuous venous infusion of 0.1–0.6 mg/kg/h. Midazolam is well absorbed also IM and SC, and can be given at the same doses when venous access in not feasible;

midazolam as oral or atomized nasal preparations is also an alternative, at dose of 0.5 mg/kg, 2.5 mg for children, 6–12 months old; 5 mg 1–4 years; 7.5 mg 5–9 years; 10 mg for children 10 years or older,

or

IV diazepam 0.15–0.25 mg/kg, at rate of 5 mg/min, until a total of 20 mg in adults; may repeat once after 5min; rectal diazepam, 0.5 mg/kg or 2.5 mg for children 6–12 months old; 5 mg for 1–4 years; 7.5 mg 5–9 years; 10 mg for children 10 years, or more.

then

IV valproic acid 20–30 mg/kg infused over 15 minutes. However, higher doses, up to 25–60 mg/kg, at 3 mg/kg/min, have been used without serious side effects. This bolus must be followed by continuous infusion of 1–2 mg/kg/h*,

or

IV levetiracetam: 20–30 mg/kg in 100 mL of NaCl 0.9% or 5% glucose infused in 30 minutes: then, after 12 hours, the same in two divided doses.

If status epilepticus does not respond, consider

IV phenytoin 15 (in the elderly)–20 mg/kg, at infusion rate of no more than 50 mg/min in adults or 1 mg/kg/min in children (monitor for hypotension and electrocardigraphic QT prolongation), in normal saline, followed by a dose of 4–8 mg/kg/daily oral or IV.

If ineffective, give supplemental IV phenytoin 5 mg/kg, which can be repeated up to a total dose of 30 mg/kg.

* In some guidelines, phenytoin is suggested before valproic acid, but a number of papers have documented the successful use of IV valproate in status epilepticus, without serious cardiovascular side effects; fosphenytoin is better tolerated than phenytoin, but is not available in all countries.

and

phenobarbital IV, 20 mg/kg, infusion rate of 60 mg/min; caution with respiratory depression, mostly in patients treated before with benzodiazepines; if ineffective, supplemental IV phenobarbital 5–10 mg/kg

> 60: refractory status epilepticus

First consider:  Lacosamide: children 2–2.5 mg/kg infused in 15 minutes then the same dose bid; adults: 200–400 mg in 15 minutes, then 200 mg twice a day

Otherwise refractory status epilepticus to be treated in intensive care unit, where the patient can be treated with general anaesthesia, propofol, pentobarbital, or others drugs (Fernandez and Claassen, 2012)

Source: Data from
Fernandez, A. and Claassen, J., Refractory status epilepticus, Current Opinion in Critical Care, Volume 18, Issue 2, pp.127–131, Copyright © 2012 Lippincott Williams & Wilkins. All rights reserved.reference
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close